Medical Equipment

Neuromodulation Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the neuromodulation market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Neuromodulation Market And What Value Is Projected For 2029?

The neuromodulation market has experienced substantial expansion recently. It is projected to grow from $6.96 billion in 2024 to $7.62 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.5%. This historical growth can be attributed to the rising prevalence of chronic disorders, strong clinical evidence and research efforts, patient demand for non-invasive therapies, government initiatives and funding, the expansion of indications, and various collaborations and partnerships.

The neuromodulation market size is projected for significant expansion in the coming years. It is anticipated to reach $11.57 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 11.0%. This growth over the forecast period is attributable to several factors, including the miniaturization of devices, increased attention on neurological disorders among the aging population, wider applications in psychiatry, the adoption of patient-centric approaches, and the global expansion of healthcare access. Key trends during the forecast period encompass the integration of artificial intelligence (AI), technological advancements, the development of non-invasive neuromodulation techniques, the emergence of closed-loop neuromodulation systems, a broader range of indications, and the proliferation of wireless and wearable neuromodulation devices.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10142&type=smp

What Factors Are Boosting The Neuromodulation Market?

The increasing occurrence of neurological disorders is anticipated to boost the expansion of the neuromodulation market in the coming years. These disorders are technically defined as conditions impacting the brain, nerves distributed across the human body, and the spinal cord. Neuromodulation provides a means to treat and regulate a broad spectrum of neurological disorders and diseases, including Parkinson’s and Alzheimer’s diseases. For instance, the European Brain Council, an international health organization based in Belgium, reported in April 2022 that more than 600 neurological diseases and almost 300 psychiatric conditions were identified. Globally, 50 million individuals were suffering from Alzheimer’s and other dementias. Epilepsy, a widespread disorder, impacted 65 million people across the globe. In Europe, 10.5 million people were affected by dementia, a figure projected to rise to 18.7 million by 2050. Consequently, the increasing occurrence of neurological disorders is propelling the expansion of the neuromodulation market.

What Are The Core Segmentation Criteria In The Neuromodulation Market?

The neuromodulationmarket covered in this report is segmented –

1) By Technology: Internal Neuromodulation, External Neuromodulation (Non-invasive)

2) By Biomaterial: Polymeric Biomaterial, Metallic Biomaterial, Ceramic Biomaterial

3) By Application: Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications

4) By End-User: Hospitals, Clinics, Home Healthcare

Subsegments:

1) By Internal Neuromodulation: Implantable Devices, Intrathecal Drug Delivery Systems

2) By External Neuromodulation (Non-invasive): Transcranial Magnetic Stimulation (TMS), Transcranial Direct Current Stimulation (tDCS), Transcutaneous Electrical Nerve Stimulation (TENS), Peripheral Nerve Stimulation (PNS)

Which Emerging Trends Are Reshaping The Neuromodulation Market Landscape?

Technological advancements represent a significant trend gaining traction in the neuromodulation market. Major corporations operating within the neuromodulation market are dedicated to developing innovative technological remedies to solidify their presence. As an illustration, in January 2024, GrayMatters Health, an Israel-based entity focused on digital self-neuromodulation therapies, launched Prism, a new FDA-cleared self-neuromodulation therapy for PTSD. This inventive equipment combines an EEG cap with software, empowering patients to master control over their emotional reactions through neurofeedback. The system is engineered to complement standard psychotherapy and pharmacotherapy, equipping patients with instruments for actively addressing their symptoms. Furthermore, in December 2022, Abbott Laboratories, a US-based medical devices and healthcare organization, introduced the Eterna spinal cord stimulation (SCS) system, which is the smallest implantable, rechargeable spinal cord stimulator available. Eterna SCS incorporates Abbott’s patented low-dose BurstDR stimulation, notable as the only SCS waveform innovation backed by the highest degree of clinical evidence (1A evidence), proven to reduce pain by 23% more than conventional waveform technology approaches.

Which Players Are Shaping The Competitive Landscape Of The NeuromodulationXX Market?

Major companies operating in the neuromodulation market include Abbott Laboratories, Soterix Medical Inc., Boston Scientific Corporation, Medtronic plc, Synapse Biomedical Inc., Nevro Corp, Neuropace Inc., LivaNova PLC, Neurosigma Inc., Neuronetics Inc., Bioness Inc., Aleva Neurotherapeutics S.A., Integer Holdings Corporation, ReShape Lifesciences Inc., Inspire Medical Systems Inc., Bioventus LLC, Saluda Medical Pty Ltd, Otolith Labs Inc., Machine Medicine Inc., Inbrain Neuroelectronics SAS, Pixium Vision SA, Neuromod Devices Limited, Cognito Therapeutics Inc., PathMaker Neurosystems Inc., Dignify Therapeutics Inc., Neuronoff ApS, Neuros Medical Inc., Fisher & Paykel Healthcare Corporation Limited, Koninklijke Philips N.V., Magic Leap Inc., Omron Corporation

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/neuromodulation-global-market-report

What Regional Trends Are Shaping Growth In The Neuromodulation Market?

North America was the largest region in the neuromodulation market in 2024. The regions covered in the neuromodulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10142&type=smp

Browse Through More Reports Similar to the Global Neuromodulation Market 2025, By The Business Research Company

Neurology Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurology-devices-global-market-report

Neurodegenerative Disorder Therapeutic Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurodegenerative-disorder-therapeutic-global-market-report

Neurophysiology Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/neurophysiology-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795